José Antonio Fornos-Pérez1, N Floro Andrés-Rodríguez2, J Carlos Andrés-Iglesias3, Reyes Luna-Cano4, Javier García-Soidán5, Blanca Lorenzo-Veiga3, Rocío Mera-Gallego3, Rosario García-Riestra6. 1. Grupo Berbés de Investigación y Docencia, Grupo de Diabetes de SEFAC, Vigo, España; Grupo de Consensos de la SED, Facultad de Farmacia, Universidad de Santiago de Compostela, Cangas do Morrazo, Pontevedra, España. 2. Grupo Berbés de Investigación y Docencia, Grupo de Diabetes de SEFAC, Vigo, España. Electronic address: farmaciaalaxe@galicia.com. 3. Grupo Berbés de Investigación y Docencia, Grupo de Diabetes de SEFAC, Vigo, España. 4. Servicio Gallego de Salud, Hospital Álvaro Cunqueiro, Vigo, España. 5. Servicio Gallego de Salud, Centro de Salud O Porriño, O Porriño, Pontevedra, España. 6. Centro de Información del Medicamento, Colegio Oficial de Farmacéuticos, Pontevedra, España.
Abstract
OBJECTIVE: The aim of this study was to detect people at risk of suffering diabetes or changes in carbohydrate metabolism and to refer them for possible diagnosis to health care centres. The number of diagnoses and costs for the pharmacy were recorded. METHODS: A cross-sectional, observational study was conducted in community pharmacies in Pontevedra in September-October of 2014. The Findrisc questionnaire was completed by pharmacy users over 18 years old. If Findrisc score was ≥ 15, capillary blood glucose was measured, and the participant was referred to a physician if the value was ≥110mg/dL. The main variables included score in the Findrisc questionnaire, number of diabetes diagnosed, and cost of the service. Differences between the groups were calculated using a Chi-squared test, a Student's t test, and/or a Wilcoxon test. RESULTS: This study was conducted in 180 pharmacies on a sample of 4,222 users, including 992 (23.5%) with a high or very high risk of diabetes (F≥15). In the 1,060 basal capillary blood glucose tests performed, mean glucose level was 110.2 (SD=20.4)mg/dL (56-254). The Galician Health Service sent information about 83 of the 384 (9.1%) subjects referred to a physician: 28 (33.7%) of them were diagnosed with diabetes (3.1% of the sample), and 26 (31.3%) were diagnosed with prediabetes (2.8% of the sample). Cost per diagnosed subject was € 184.22 per subject with diabetes and € 96.86 per subject with prediabetes. CONCLUSIONS: The proportion of subjects with new diagnosis of diabetes (3.1%) shows the high efficiency of a screening program for hidden diabetics implemented at community pharmacies as the one presented here.
OBJECTIVE: The aim of this study was to detect people at risk of suffering diabetes or changes in carbohydrate metabolism and to refer them for possible diagnosis to health care centres. The number of diagnoses and costs for the pharmacy were recorded. METHODS: A cross-sectional, observational study was conducted in community pharmacies in Pontevedra in September-October of 2014. The Findrisc questionnaire was completed by pharmacy users over 18 years old. If Findrisc score was ≥ 15, capillary blood glucose was measured, and the participant was referred to a physician if the value was ≥110mg/dL. The main variables included score in the Findrisc questionnaire, number of diabetes diagnosed, and cost of the service. Differences between the groups were calculated using a Chi-squared test, a Student's t test, and/or a Wilcoxon test. RESULTS: This study was conducted in 180 pharmacies on a sample of 4,222 users, including 992 (23.5%) with a high or very high risk of diabetes (F≥15). In the 1,060 basal capillary blood glucose tests performed, mean glucose level was 110.2 (SD=20.4)mg/dL (56-254). The Galician Health Service sent information about 83 of the 384 (9.1%) subjects referred to a physician: 28 (33.7%) of them were diagnosed with diabetes (3.1% of the sample), and 26 (31.3%) were diagnosed with prediabetes (2.8% of the sample). Cost per diagnosed subject was € 184.22 per subject with diabetes and € 96.86 per subject with prediabetes. CONCLUSIONS: The proportion of subjects with new diagnosis of diabetes (3.1%) shows the high efficiency of a screening program for hidden diabetics implemented at community pharmacies as the one presented here.
Authors: Cassyano J Correr; Wendel Coura-Vital; Josélia C Q P Frade; Renata C R M Nascimento; Lúbia G Nascimento; Eliete B Pinheiro; Wesley M Ferreira; Janice S Reis; Karla F S Melo; Roberto Pontarolo; Mônica S A Lenzi; José V Almeida; Hermelinda C Pedrosa; Walter S J João Journal: Diabetol Metab Syndr Date: 2020-10-08 Impact factor: 3.320
Authors: Emma Barron; Shivani Misra; Emma English; W Garry John; Michael Sampson; Max O Bachmann; Julian Barth; Nick Oliver; K G M M Alberti; Chirag Bakhai; Simon O'Neill; Bob Young; Nicholas J Wareham; Kamlesh Khunti; Susan Jebb; Jenifer Smith; Jonathan Valabhji Journal: BMJ Open Diabetes Res Care Date: 2020-12